HALO
Closed
Halozyme Therapeutics Inc
52.92
+0.90 (+1.73%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 52.02
Day's Range: 51.78 - 53.3124
Send
sign up or login to leave a comment!
When Written:
38.39
Halozyme Therapeutics Inc. is a biotechnology company that develops and commercializes novel oncology therapies and drug delivery technologies. The company's proprietary enzyme platform technology, known as Enhanze, is used to enhance the delivery and efficacy of biologics, including monoclonal antibodies and therapeutic proteins. Halozyme also has a pipeline of proprietary oncology therapies, including PEGPH20, a novel enzyme that targets the tumor microenvironment and is being developed for the treatment of pancreatic cancer. The company is headquartered in San Diego, California and was founded in 1998.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








